{"brief_title": "Treatment of Nonalcoholic Fatty Liver Disease in Children (TONIC)", "brief_summary": "The purpose of this study is to determine if therapeutic modification of insulin resistance or oxidative stress leads to improvement in serum or histologic indicators of liver injury or quality of life.", "condition": ["Fatty Liver"], "intervention_type": ["Drug", "Dietary Supplement", "Drug"], "intervention_name": ["Metformin", "Vitamin E", "Matching placebo"], "description": ["500 mg, twice daily", "400 IU, twice daily", "Twice daily"], "arm_group_label": ["1", "2", "3"], "other_name": ["Nature Made"], "criteria": "- Age 8-17 years at first screening visit - Histologic evidence of Nonalcoholic Fatty Liver Disease (NAFLD) - biopsy cannot be older than 6 months as of randomization - ALT level >60 U/L at time of screening and on one previous occasion determined at least one month but no greater than 6 months prior to screening ALT - Consent", "gender": "All", "minimum_age": "8 Years", "maximum_age": "17 Years", "healthy_volunteers": "No", "keyword": "Non alcoholic fatty liver disease", "mesh_term": ["Liver Diseases", "Fatty Liver", "Non-alcoholic Fatty Liver Disease", "Vitamins", "Vitamin E", "Tocopherols", "Tocotrienols", "alpha-Tocopherol", "Metformin"], "id": "NCT00063635"}